Profil Financier
Per Sandberg occupe actuellement le rang #2036 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $2.0 B (-$337 sur 24h).
Per Sandberg is a major shareholder in pharmaceutical company Camurus, which develops treatment for opiod dependency.
He inherited the stakes from his father, entrepreneur Gunnar Sandberg.
He is also the sole owner of Aimpoint ? the world leader in red dot sights for hunting, sport shooting, and military use.
Sandberg Development is his family-owned investment company, focusing on water technology, quality of life, and security.
Per Sandberg has three siblings, all of whom have been bought out of Sandberg Development. He now owns the company together with his three sons.